Airsculpt Technologies is trading 7.9% down at $4.32 amid general risk-off sentiment toward smaller healthcare names, suggesting idiosyncratic weakness rather than sector-driven pressure.
- The stock is underperforming the broader Healthcare sector, which is currently trading higher on the back of strong large-cap earnings.
- There are no fresh company-specific catalysts, such as earnings releases or analyst actions, reported for today's session.